\-\ Texto\\:\\ \ \(0\)\
\-\ high\\ dose\\ steroid\\ therapy\\.\ \(0\)\
\-\ amorphous\\ soft\\ tissue\\ swelling\\ in\\ the\\ periorbital\\ soft\\ tissues\\ on\\ the\\ left\\,\\ pronounced\\ asymmetric\\ swelling\\ of\\ the\\ extraocular\\ muscles\\ \\(extending\\ to\\ the\\ tendinous\\ insertions\\)\\ and\\ inflammatory\\ changes\\ of\\ the\\ intraconal\\ fat\\.\ \(0\)\
\-\ orbital\\ pseudotumor\ \(6\)\
\-\ thyroid\\ eye\\ disease\ \(0\)\
\-\ orbital\\ myositis\ \(1\)\
\-\ sjogren\\'s\\ disease\ \(0\)\
\-\ orbital\\ pseudotumor\ \(6\)\
\-\ infections\\ orbital\\ cellulitis\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ 30\\ yo\\ woman\\ with\\ acute\\ onset\\ of\\ eye\\ pain\\ and\\ left\\ eye\\ swelling\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ orbital\\:\\ 0\\.2349764921257242\ \(0\)\
\-\ eye\\:\\ 0\\.15584390465703962\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.14331354820459732\ \(0\)\
\-\ swelling\\:\\ 0\\.12377438539048402\ \(0\)\
\-\ sjogren\\:\\ 0\\.09955954021610414\ \(0\)\
\-\ insertions\\:\\ 0\\.09762430264183568\ \(0\)\
\-\ tendinous\\:\\ 0\\.0959173021250765\ \(0\)\
\-\ intraconal\\:\\ 0\\.0917479967272246\ \(0\)\
\-\ amorphous\\:\\ 0\\.08670007362188815\ \(0\)\
\-\ periorbital\\:\\ 0\\.08231919142083115\ \(0\)\
\-\ pronounced\\:\\ 0\\.07846842090296148\ \(0\)\
\-\ myositis\\:\\ 0\\.07846842090296148\ \(0\)\
\-\ extraocular\\:\\ 0\\.07582607950015056\ \(0\)\
\-\ cellulitis\\:\\ 0\\.07359201167656709\ \(0\)\
\-\ steroid\\:\\ 0\\.06538338160525113\ \(0\)\
\-\ dose\\:\\ 0\\.06480743481322919\ \(0\)\
\-\ soft\\:\\ 0\\.06031671779691449\ \(0\)\
\-\ asymmetric\\:\\ 0\\.0601750627515135\ \(0\)\
\-\ infections\\:\\ 0\\.058868525113914986\ \(0\)\
\-\ muscles\\:\\ 0\\.05656323968449922\ \(0\)\
\-\ tissues\\:\\ 0\\.05082972067485932\ \(0\)\
\-\ thyroid\\:\\ 0\\.05075815137572045\ \(0\)\
\-\ 30\\:\\ 0\\.04762448313703007\ \(0\)\
\-\ inflammatory\\:\\ 0\\.042946607886840925\ \(0\)\
\-\ extending\\:\\ 0\\.04163360940347532\ \(0\)\
\-\ disease\\:\\ 0\\.040485146122194324\ \(0\)\
\-\ onset\\:\\ 0\\.03909306124529203\ \(0\)\
\-\ fat\\:\\ 0\\.03766539598379179\ \(0\)\
\-\ yo\\:\\ 0\\.03726596410583713\ \(0\)\
\-\ changes\\:\\ 0\\.03549344893094291\ \(0\)\
\-\ lymphoma\\:\\ 0\\.035394183107093996\ \(0\)\
\-\ high\\:\\ 0\\.033891971899663996\ \(0\)\
\-\ therapy\\:\\ 0\\.03311073617740019\ \(0\)\
\-\ acute\\:\\ 0\\.030577961291398482\ \(0\)\
\-\ tissue\\:\\ 0\\.029353930267428895\ \(0\)\
\-\ woman\\:\\ 0\\.02860728909404212\ \(0\)\
\-\ left\\:\\ 0\\.027713196210809123\ \(0\)\
\-\ \\'s\\:\\ 0\\.027305023454594856\ \(0\)\
\-\ pain\\:\\ 0\\.015124756051170068\ \(0\)\
\-\ on\\:\\ 0\\.010491174092252581\ \(0\)\
\-\ \\(\\:\\ 0\\.010469010525273341\ \(0\)\
\-\ \\)\\:\\ 0\\.010341125972656596\ \(0\)\
\-\ the\\:\\ 0\\.010018064108958391\ \(0\)\
\-\ to\\:\\ 0\\.006189392875985308\ \(0\)\
\-\ in\\:\\ 0\\.006107206233916738\ \(0\)\
\-\ and\\:\\ 0\\.005217652340064303\ \(0\)\
\-\ of\\:\\ 0\\.005065382643390801\ \(0\)\
\-\ \\,\\:\\ 0\\.0039233342828592374\ \(0\)\
\-\ with\\:\\ 0\\.0016957126969549237\ \(0\)\
\-\ \\.\\:\\ 0\\.0010289720607926456\ \(0\)\
